Correlation Between Clal Biotechnology and Tadir Gan
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Tadir Gan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Tadir Gan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Tadir Gan 1993, you can compare the effects of market volatilities on Clal Biotechnology and Tadir Gan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Tadir Gan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Tadir Gan.
Diversification Opportunities for Clal Biotechnology and Tadir Gan
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Clal and Tadir is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Tadir Gan 1993 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tadir Gan 1993 and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Tadir Gan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tadir Gan 1993 has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Tadir Gan go up and down completely randomly.
Pair Corralation between Clal Biotechnology and Tadir Gan
Assuming the 90 days trading horizon Clal Biotechnology is expected to generate 3.09 times less return on investment than Tadir Gan. But when comparing it to its historical volatility, Clal Biotechnology Industries is 1.72 times less risky than Tadir Gan. It trades about 0.06 of its potential returns per unit of risk. Tadir Gan 1993 is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 18,310 in Tadir Gan 1993 on December 20, 2024 and sell it today you would earn a total of 3,180 from holding Tadir Gan 1993 or generate 17.37% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Clal Biotechnology Industries vs. Tadir Gan 1993
Performance |
Timeline |
Clal Biotechnology |
Tadir Gan 1993 |
Clal Biotechnology and Tadir Gan Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Clal Biotechnology and Tadir Gan
The main advantage of trading using opposite Clal Biotechnology and Tadir Gan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Tadir Gan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tadir Gan will offset losses from the drop in Tadir Gan's long position.Clal Biotechnology vs. Kamada | Clal Biotechnology vs. BioLine RX | Clal Biotechnology vs. Evogene | Clal Biotechnology vs. Bezeq Israeli Telecommunication |
Tadir Gan vs. WhiteSmoke Software | Tadir Gan vs. Victory Supermarket Chain | Tadir Gan vs. Computer Direct | Tadir Gan vs. Bank Leumi Le Israel |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |